Baykul Timucin, Alanoglu E Guchan, Kocer Gulperi
Department of Oral and Maxillofacial Surgery, School of Dentistry, University of Suleyman Demirel, Isparta, Turkey.
J Contemp Dent Pract. 2010 Jan 1;11(1):E088-94.
To determine the efficacy of the topical application of Ankaferd Blood Stopper (ABS) on hemorrhagic diathesis following dental procedures under different conditions.
Some patients have a tendency to bleed excessively after dental surgery for a variety of reasons, making oral surgical procedures more risky for these patients. Since hemorrhage can cause major morbidity and mortality, the identification of a novel, effective hemostatic agent could improve the management of excessive bleeding that occurs during dental procedures.
Four patients (3 females, 1 male) aged 28-45 with bleeding tendencies due to different presurgical conditions such as von Willebrand Disease, chronic liver failure, and mitral valve replacement presented for tooth extraction. Hematological consultations were obtained prior to surgical intervention and their international normalized (INR) ratio values were adjusted to less than 1.5; none received clotting factor replacement. All the extractions were performed under local anesthesia with and without epinephrine. In the presence of postsurgical bleeding, the efficacy of the ampule form of topical ABS was observed. Sex, age, anamnesis, von Willebrand Factor, activated partial thromboplastin time, factor VIII, and platelet counts of patients were recorded prior to the extractions.
ABS was found to be effective within 10 to 20 minutes in controlling bleeding in most of the patients after dental surgery. These observations suggest the use of ABS may be a beneficial hemostatic agent for use in patients with hemorrhagic diathesis following tooth extraction. Additional research is needed to clarify the role of this unique medicinal product in the surgical treatment of dental patients with bleeding tendency.
ABS has demonstrated potential for being an effective hemostatic agent for the treatment of excessive bleeding following dental surgery in four patients with hemorrhagic diathesis.
确定在不同条件下,局部应用安卡福得止血剂(ABS)对牙科手术后出血素质的疗效。
由于多种原因,一些患者在牙科手术后有过度出血的倾向,这使得口腔外科手术对这些患者来说风险更高。由于出血可导致严重的发病率和死亡率,因此,确定一种新型、有效的止血剂可改善牙科手术期间发生的过度出血的处理。
4例患者(3例女性,1例男性),年龄28 - 45岁,因不同的术前状况如血管性血友病、慢性肝功能衰竭和二尖瓣置换术而有出血倾向,前来拔牙。在手术干预前进行了血液学会诊,并将他们的国际标准化比值(INR)调整至小于1.5;均未接受凝血因子替代治疗。所有拔牙均在局部麻醉下进行,使用或不使用肾上腺素。在术后出血的情况下,观察了安瓿剂型局部应用ABS的疗效。在拔牙前记录了患者的性别、年龄、既往史、血管性血友病因子、活化部分凝血活酶时间、凝血因子VIII和血小板计数。
发现ABS在大多数牙科手术后患者中,能在10至20分钟内有效控制出血。这些观察结果表明,对于拔牙后有出血素质的患者,使用ABS可能是一种有益的止血剂。需要进一步研究来阐明这种独特药物产品在有出血倾向的牙科患者手术治疗中的作用。
对于4例有出血素质的患者,ABS已显示出作为治疗牙科手术后过度出血的有效止血剂的潜力。